Scripps Research identifies erucamide as retinal defense signal against vision loss
This digest was compiled by AI from multiple sources — links to the originals are below.
Researchers at Scripps Research, with UC San Diego and the Lowy Medical Research Institute, identified the naturally occurring molecule erucamide as a coordinator of retinal cell communication. The team found erucamide levels decline as photoreceptors die, and restoring it stabilized retinal tissue in a study published in Nature Neuroscience on June 19, 2026. The findings suggest the retina actively protects itself, even as diseases like diabetic retinopathy and age-related macular degeneration progressively damage vision.
Key Facts
- Erucamide is a naturally occurring molecule that helps coordinate communication between cells in the retina.
- The study was published in Nature Neuroscience on June 19, 2026.
- Erucamide levels decline as photoreceptors, the light-sensing cells responsible for detecting visual information, begin to die.
- Restoring erucamide activated cellular responses that helped stabilize retinal tissue.
- The research involved scientists from Scripps Research, UC San Diego, and the Lowy Medical Research Institute.
Retinal Defense Mechanism
The retina actively responds to injury rather than simply deteriorating, according to senior author Martin Friedlander, a professor at Scripps Research. Erucamide acts as a signaling molecule that helps coordinate this protective response. Keeping the retina healthy requires constant coordination among neurons, glia, blood vessels, and immune cells, which together form the neurovascular unit. This coordination breaks down in diseases such as diabetic retinopathy, retinitis pigmentosa, and age-related macular degeneration.
Research Origins and Methods
Friedlander's team began the study after earlier research showed transplanted stem cell-derived retinal cells appeared to slow degeneration even after the transplanted cells themselves had disappeared. That finding suggested the cells might have been releasing protective chemical signals whose effects lasted longer than the cells. The researchers used mass spectrometry-based metabolomics to measure many small molecules in tissue at once and search for possible protective signals. Lipids, a broad group of fat-like compounds, can act as signaling molecules carrying instructions between cells, yet many lipid-related molecules have received relatively little attention in retinal disease.
1 source
Time · lag behind first